Danaher | DHR - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.66B 38.87M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Bio Techne USD 688.05M 50.62M 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
ESCO Technologies USD 726.79M 37.14M 2026-03
Fortive USD 1.55B 58.5M 2026-03
Henry Schein USD 4.5B 32M 2026-03
Illumina USD 2.74B 551M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Keysight Technologies USD 5.04B 341M 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Medtronic USD 24.07B 75M 2025-12
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
OraSure Technologies USD 240.78M 21.13M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Quidel USD 1.38B 70.3M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Roper Industries USD 1.91B 16M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Waters USD 3.72B 1.73B 2026-03
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03